Back to Search
Start Over
Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.
- Source :
-
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2017 Aug; Vol. 18 (11), pp. 1137-1143. Date of Electronic Publication: 2017 Jul 09. - Publication Year :
- 2017
-
Abstract
- Introduction: Olopatadine hydrochloride is an antihistamine and mast cell stabilizer available as oral, intranasal and ocular preparations. Most of the practical applications of olopatadine therapy focus on the treatment of allergic rhinoconjunctivitis via intranasal and ocular routes. Areas covered: This article was created from a comprehensive literature search with information taken from meta-analyses, systematic reviews, and clinical trials of children and adults. The articles that have been selected, evaluate the use of intranasal and ocular antihistamines and their role in allergic rhinoconjunctivitis. Expert opinion: Olopatadine is significantly more effective than placebos in relieving the symptoms of allergic rhinoconjunctivitis. It can function both as a viable alternative or addition to first line therapies such as intranasal steroids and oral antihistamines.
- Subjects :
- Administration, Intranasal
Administration, Ophthalmic
Administration, Oral
Adult
Anti-Allergic Agents administration & dosage
Anti-Allergic Agents adverse effects
Clinical Trials as Topic
Histamine H1 Antagonists administration & dosage
Histamine H1 Antagonists adverse effects
Humans
Olopatadine Hydrochloride administration & dosage
Olopatadine Hydrochloride adverse effects
Olopatadine Hydrochloride pharmacokinetics
Ophthalmic Solutions therapeutic use
Treatment Outcome
Anti-Allergic Agents therapeutic use
Conjunctivitis, Allergic drug therapy
Histamine H1 Antagonists therapeutic use
Olopatadine Hydrochloride therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1744-7666
- Volume :
- 18
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Expert opinion on pharmacotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 28656804
- Full Text :
- https://doi.org/10.1080/14656566.2017.1346085